Skip to main content
SpringerLink
Log in

Cutaneous and Temporal Bone Malignancies

  • Chapter
  • First Online:
ENT Board Prep

Abstract

Basal cell carcinoma (BCC) body distribution = 85 % head and neck (most commonly nasal tip and alae of nose) BCC 4× more common on embryonic fusion planes than other regions of midface Cutaneous SCC most common index lesion site: the lateral aspect of head and the ear Cutaneous SCC most common met site: parotid (75 %) and upper cervical nodes Prognostic factors for melanoma include the number of metastatic lymph nodes, tumor burden and primary tumor ulceration, satellite and in-transit metastasis High-dose interferon-a 2b is the only FDA-approved adjuvant therapy for stage III melanoma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

REFERENCES

  1. Anbari KK, et al. Melanoma of unknown primary site: presentation, treatment and prognosis—a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer. 1997;79(9):1816–21.

    Article  PubMed  CAS  Google Scholar 

  2. Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, Owens M, Stampone P, Gollnick H. Recurrence rate of suprficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol. 2005;15:374–81.

    PubMed  Google Scholar 

  3. Berner A. Actinic keratosis and development of squamous cell carcinoma of the skin. J Norwegian Med Assoc. 2005;125:1653–4.

    Google Scholar 

  4. Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011;65(5):1032–47.

    Article  PubMed  Google Scholar 

  5. Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R, Cormier JN, Xing Y. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma: a meta-analysis. J Natl Cancer Inst. 2011;103(2):129–42.

    Article  PubMed  Google Scholar 

  6. Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, Veronesi U, et al. Thin Stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318:1159–62.

    Article  PubMed  Google Scholar 

  7. Chute D, Stelow E. Cytology of head and neck squamous cell carcinoma variants. Diagn Cytopathol. 2010;38(1):65–80.

    PubMed  Google Scholar 

  8. Clark Jr WH, Tucker MA, Kraemer KH, Elder DE, Fraser MC, Greene MH. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985;102(4):458–65.

    Article  PubMed  Google Scholar 

  9. Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, Morton DL, et al. Sentinal node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an internaltional multicenter trial. Ann Surg. 2005;242:302–13.

    PubMed  Google Scholar 

  10. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol. 1995;33(6):923–40.

    Article  PubMed  CAS  Google Scholar 

  11. Cormier JN. Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer. 2006;106(9):2012–20.

    Article  PubMed  Google Scholar 

  12. D’Sousa J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2011;19(2):99–105.

    Article  Google Scholar 

  13. Dafni U, Bafaloukos D, Skarlos D, Polyzos A, Tsoutsos D, Pectasides D. Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patient with resected high-risk melanoma. J Clin Oncol. 2009;27(6):939–44.

    Article  PubMed  Google Scholar 

  14. Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, Eggermont AM, et al. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomized phase III trial. Lancet. 2008;372(9633):117–26.

    Article  PubMed  CAS  Google Scholar 

  15. Fisher SR. Elective, therapeutic and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998. Laryngoscope. 2002;112(1):99–110.

    Article  PubMed  Google Scholar 

  16. Flaherty KT, Fecher LA. Where are we with adjuvant therapy of stage III and IV melanoma in 2009? J Natl Compr Canc Netw. 2009;7(3):295–304.

    PubMed  Google Scholar 

  17. Gidley PW. Managing malignancies of external auditory canal. Expert Rev Anticancer Ther. 2009;9(9):1277–82.

    Article  PubMed  Google Scholar 

  18. Goh YH, Chan YM, Chong VF, Low WK, Lim LH. Malignancy of the temporal bone and external auditory canal. Otolaryngol Head Neck Surg. 2000;122(6):882–6.

    Article  PubMed  Google Scholar 

  19. Goldstein AM, Tucker MA. Melanoma etiology: where are we? Oncogene. 2003;22(20):3042–52.

    Article  PubMed  Google Scholar 

  20. Hamilton T, Lowe L, Johnson TM. Multiple primary melanomas. J Am Acad Dermatol. 1998;39(3):422–7.

    Article  PubMed  Google Scholar 

  21. Kirkwood JM, Konstantinopoulos PA, Moschos SJ. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b. J Clin Oncol. 2004;22(1):11–4.

    PubMed  Google Scholar 

  22. Kroon BB, Rümke P, Mooi WJ, Hart AA, van Dongen JA, Jonk A. Lymph node metastasis from melanoma with an unknown primary site. Br J Surg. 1990;77(6):665–8.

    Article  PubMed  Google Scholar 

  23. Leffell DJ, Newman JC. Correlation of embryonic fusion planes with the anatomical distribution of basal cell carcinoma. Dermatol Surg. 2007;33(8):957–64.

    Article  PubMed  Google Scholar 

  24. Liegeois N, Farasat S, et al. A new American Jo int Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol. 2011;64(6):1051–9.

    Article  PubMed  Google Scholar 

  25. Marghoob AA, Kopf AW, Koenig KL, Bart RS, Bittencourt FV. Large congenital melanocytic nevi and risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics. 2000;106(4):736–41.

    Article  PubMed  Google Scholar 

  26. Myers JN, Lentsch EJ. Melanoma of the head and neck: current concepts in diagnosis and management. Laryngoscope. 2001;111(7):1209–22.

    Article  PubMed  Google Scholar 

  27. O’Hara J, Ferlito A, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland—a review of current recommendations. Head Neck. 2011;33(12):1789–95.

    Article  PubMed  Google Scholar 

  28. Padgett J. Cutaneous lesions: benign and malignant. Facial Plast Surg Clin North Am. 2005;13(2):195–202.

    Article  PubMed  Google Scholar 

  29. Pasha R. Otolaryngology head and neck surgery. San Diego: Plural Publishing, Inc.; 2011.

    Google Scholar 

  30. Perkins W. Who should have Mohs’ micrographic surgery? Curr Opin Otolaryngol Head Neck Surg. 2010;18(4):283–9.

    Article  PubMed  Google Scholar 

  31. Rowe D, Carroll R, Day CJ. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol. 1992;26(6):976–90.

    Article  PubMed  CAS  Google Scholar 

  32. Samarasinghe V, Madan V, Lear J. Management of high-risk squamous cell carcinoma of the skin. Expert Rev Anticancer Ther. 2011;11(5):763–9.

    Article  PubMed  Google Scholar 

  33. Shive ML, Chren MM, Han J, Qureshi AA, Linos E, Wehner MR. Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ. 2012;345:e5909.

    Article  PubMed  Google Scholar 

  34. Tsai ST, Li C, Chang KC, Yan JJ, Chao WY, Jin YT, et al. Prevalence of human papillomavirus in middle ear carcinoma associated with chronic otitis media. Am J Pathol. 1997;150(4):1327–33.

    PubMed  Google Scholar 

  35. Wagstaff SA, Hardy DG, Moffat DA. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope. 2005;115(2):341–7.

    Article  PubMed  Google Scholar 

  36. Walvekar RR, Arriaga MA, Dileo MD, Nuss DW, Pou AM, Hagan J, Lin J, Gaudet JE. Applicability of the pittsburgh staging system for advanced cutaneous malignancy of the temporal bone. Skull Base. 2010;20(6):409–14.

    Article  PubMed  Google Scholar 

  37. Yilmaz I, et al. Endolymphatic sac papillary tumor: a case report and review. Auris Nasus Larynx. 2008;35(2):276–81.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology–Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA

    Hailun Wang

  2. Department of Otolaryngology–Head and Neck Surgery, The Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, 1189, New York, NY, 10029, USA

    Brett A. Miles

Authors
  1. Hailun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brett A. Miles
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Otolaryngology, Mount Sinai School of Medicine, New York, New York, USA

    Fred Lin

  2. Department of Otolaryngology/Head & Neck Endoscopic Sinus and Skull Base Surgery, Emory University, Atlanta, Georgia, USA

    Zara Patel

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wang, H., Miles, B.A. (2014). Cutaneous and Temporal Bone Malignancies. In: Lin, F., Patel, Z. (eds) ENT Board Prep. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8354-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8354-0_24

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8353-3

  • Online ISBN: 978-1-4614-8354-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation